Administration of Clomiphene: Short and Long Term Metabolism in an Anti-Doping Setting
Status:
Completed
Trial end date:
2018-10-15
Target enrollment:
Participant gender:
Summary
Clomiphene (Clomid) is a drug FDA approved to treat female infertility, however, it is often
used by men in an off-label setting to both treat male infertility and in a multitude of
sports disciplines to increase performance.
Study Objectives:
- Determine detection windows for clomiphene and its metabolites in urine following a
medium-term administration
- Understand the effect of clomiphene administration on luteinizing hormone (LH),
follicle-stimulating hormone (FSH), and serum testosterone (T) concentrations in a
longitudinal manner
- Identify changes in current steroidal module of Athlete Biological Passport
Phase:
Phase 1
Details
Lead Sponsor:
Stuart Willick
Collaborators:
Partnership for Clean Competition Sports Medicine Research and Testing Laboratory